Jupiter Endovascular, Inc. announced that the full results of the SPIRARE II pivotal trial, evaluating the company’s Vert ...

Haemonetics Corporation announced FDA approval of the PerQseal Elite vascular closure system for large-bore arterial procedures ...

Penumbra, Inc. announced that the FDA has granted clearance for the treatment of deep vein thrombosis (DVT) to the company&rsqu ...

Gore & Associates announced FDA approval of an expanded indication for the company’s Viabahn VBX balloon expandable e ...

Sonorous Neurovascular announced that the FDA approved an investigational device exemption (IDE) authorizing the company to ...

Results from the prospective, single-arm, multicenter POWER PAD II study demonstrated that the Pulse intravascular lithotripsy ...

Stryker Peripheral Vascular announced that the American Medical Association (AMA) Current Procedural Terminology (CPT) ...

A secondary analysis of the randomized SirPAD trial demonstrated lower rates of target-lesion revascularization (TLR) and major ...

Six-month results from Esprit BTK PAS were reported in patients with chronic limb-threatening ischemia (CLTI) treated with the ...

At VIVA 2026, the Vascular InterVentional Advances conference, William A. Gray, MD, presented findings from a subgroup analysis ...

One-year results from the prospective, multicenter, single-arm PROMISE III trial evaluated transcatheter arterialization of the ...

Reva Medical, LLC announced the presentation of results from a subgroup analysis of the MOTIV BTK pivotal trial for the ...